Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endopeptidases | 5 | 2017 | 14 | 1.740 |
Why?
| | Prostatic Neoplasms | 4 | 2017 | 120 | 1.230 |
Why?
| | Sumoylation | 2 | 2016 | 4 | 0.740 |
Why?
| | Cysteine Endopeptidases | 1 | 2017 | 9 | 0.480 |
Why?
| | PTEN Phosphohydrolase | 1 | 2017 | 12 | 0.470 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2017 | 29 | 0.470 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2016 | 1 | 0.450 |
Why?
| | Origin Recognition Complex | 1 | 2016 | 2 | 0.450 |
Why?
| | Genomic Instability | 1 | 2016 | 2 | 0.450 |
Why?
| | Histones | 1 | 2016 | 15 | 0.440 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 34 | 0.440 |
Why?
| | Aurora Kinase A | 1 | 2014 | 1 | 0.410 |
Why?
| | Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 3 | 0.400 |
Why?
| | beta Catenin | 1 | 2014 | 17 | 0.400 |
Why?
| | Cell Line, Tumor | 5 | 2016 | 169 | 0.400 |
Why?
| | Carcinoma, Renal Cell | 1 | 2014 | 43 | 0.390 |
Why?
| | Kidney Neoplasms | 1 | 2014 | 63 | 0.380 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 2 | 2016 | 6 | 0.360 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2017 | 50 | 0.360 |
Why?
| | Cardiotoxins | 1 | 2012 | 1 | 0.350 |
Why?
| | Mitochondrial Turnover | 1 | 2012 | 1 | 0.350 |
Why?
| | Doxorubicin | 1 | 2012 | 11 | 0.350 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2012 | 17 | 0.350 |
Why?
| | Myocytes, Cardiac | 1 | 2012 | 47 | 0.340 |
Why?
| | Humans | 9 | 2017 | 7258 | 0.330 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2010 | 4 | 0.300 |
Why?
| | Mice | 4 | 2017 | 1116 | 0.280 |
Why?
| | Animals | 5 | 2017 | 3827 | 0.260 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2014 | 11 | 0.260 |
Why?
| | Receptors, Adrenergic, alpha-2 | 1 | 2007 | 10 | 0.250 |
Why?
| | Epinephrine | 1 | 2007 | 44 | 0.250 |
Why?
| | Receptors, Androgen | 1 | 2007 | 11 | 0.250 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2007 | 53 | 0.240 |
Why?
| | Transcription, Genetic | 1 | 2007 | 168 | 0.230 |
Why?
| | RNA, Messenger | 3 | 2012 | 230 | 0.200 |
Why?
| | Apoptosis | 2 | 2017 | 121 | 0.190 |
Why?
| | Immunohistochemistry | 2 | 2017 | 170 | 0.190 |
Why?
| | Mice, Transgenic | 2 | 2017 | 196 | 0.180 |
Why?
| | Male | 4 | 2017 | 4565 | 0.170 |
Why?
| | Transfection | 2 | 2012 | 134 | 0.140 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 383 | 0.140 |
Why?
| | SUMO-1 Protein | 2 | 2010 | 6 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 109 | 0.130 |
Why?
| | Cell Proliferation | 2 | 2010 | 118 | 0.130 |
Why?
| | Protein Stability | 1 | 2017 | 12 | 0.120 |
Why?
| | Immunoprecipitation | 1 | 2017 | 31 | 0.120 |
Why?
| | Immunoblotting | 1 | 2017 | 50 | 0.120 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2016 | 3 | 0.110 |
Why?
| | Centromere | 1 | 2016 | 6 | 0.110 |
Why?
| | G2 Phase | 1 | 2016 | 3 | 0.110 |
Why?
| | Methylation | 1 | 2016 | 14 | 0.110 |
Why?
| | DNA Repair | 1 | 2016 | 20 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2017 | 312 | 0.100 |
Why?
| | Cilia | 1 | 2014 | 4 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2014 | 90 | 0.090 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2012 | 2 | 0.090 |
Why?
| | Sequence Deletion | 1 | 2012 | 17 | 0.090 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 85 | 0.090 |
Why?
| | Cell Growth Processes | 1 | 2012 | 5 | 0.090 |
Why?
| | Heart Failure | 1 | 2012 | 33 | 0.090 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 41 | 0.090 |
Why?
| | Neoplasm Metastasis | 1 | 2012 | 23 | 0.090 |
Why?
| | Mice, Nude | 1 | 2012 | 29 | 0.090 |
Why?
| | Disease Progression | 1 | 2012 | 90 | 0.080 |
Why?
| | Amino Acid Sequence | 1 | 2012 | 271 | 0.080 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 100 | 0.080 |
Why?
| | Cell Line | 1 | 2012 | 266 | 0.080 |
Why?
| | Mice, Knockout | 1 | 2012 | 210 | 0.080 |
Why?
| | DNA-Binding Proteins | 1 | 2012 | 181 | 0.080 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 27 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 224 | 0.070 |
Why?
| | Protein Isoforms | 1 | 2010 | 34 | 0.070 |
Why?
| | Blotting, Western | 1 | 2010 | 147 | 0.070 |
Why?
| | Protein Transport | 1 | 2010 | 73 | 0.070 |
Why?
| | Brimonidine Tartrate | 1 | 2007 | 7 | 0.060 |
Why?
| | G-Protein-Coupled Receptor Kinase 3 | 1 | 2007 | 12 | 0.060 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 1 | 2007 | 7 | 0.060 |
Why?
| | Adrenergic alpha-Agonists | 1 | 2007 | 14 | 0.060 |
Why?
| | G-Protein-Coupled Receptor Kinase 2 | 1 | 2007 | 16 | 0.060 |
Why?
| | Adrenergic beta-2 Receptor Antagonists | 1 | 2007 | 11 | 0.060 |
Why?
| | Propranolol | 1 | 2007 | 37 | 0.060 |
Why?
| | Quinoxalines | 1 | 2007 | 18 | 0.060 |
Why?
| | Androgens | 1 | 2007 | 9 | 0.060 |
Why?
| | Norepinephrine | 1 | 2007 | 106 | 0.060 |
Why?
| | In Situ Hybridization | 1 | 2007 | 31 | 0.060 |
Why?
| | Cyclic AMP | 1 | 2007 | 123 | 0.060 |
Why?
| | Cell Membrane | 1 | 2007 | 116 | 0.060 |
Why?
| | Base Sequence | 1 | 2007 | 308 | 0.060 |
Why?
|
|
Bawa-Khalfe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|